Translational Responsive Medicine Center
Translational research: Stimulation to Response, Diagnosis to Therapy, Basic to Clinical, Lab to Market
Translational Responsive Medicine Center
The Translational Responsive Medicine Center leads the future field of biomedical engineering through the development of advanced technologies in nanobiotechnology, tissue engineering, cell engineering, and precision high-throughput screening technology. Its focus is on precision diagnosis and personalized treatment of rare diseases.
Research Goals
- Development and commercialization of ultra-precision biomedical engineering technologies for the diagnosis and treatment of rare diseases.
- Activation of startups in the field of precision tailored therapeutic drugs and diagnostics, aligning with future mega-trends.
- Maximizing synergy with the Daegu-Gyeongbuk Advanced Medical Complex and contributing to the mutual growth of the local community with DGIST.
Major Research Fields & Contents
- Disease mimic biochips
- Biomimetics
- 3D bioprinting
- Ultra-precision tissue engineering
- Precision biological stimulation technology
- Physiological stimulation (ultrasound, electrical, etc.)-based biological changes
- Drug-physical stimulation-based high-throughput screening platform
- Liquid biopsy-based disease diagnosis and cell engineering-based immunotherapy
- Precise separation of cells and exosomes through Lab-on-a-disc technology
- Cell therapy
Director
Minseok S. Kim
Tel
053-785-1740
E-mail
kms@dgist.ac.kr